NCT01988922View on ClinicalTrials.gov

CYP2B6 Polymorphisms in Ketamine

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

ketamine

0.4 mg/kg oral racemic ketamine

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT01988922 - CYP2B6 Polymorphisms in Ketamine | Biotech Hunter | Biotech Hunter